COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

Adults with Down Syndrome (DS) are at higher risk for severe outcomes of coronavirus disease 2019 (COVID-19) than the general population, but evidence is required to understand the risks for children with DS, which is necessary to inform COVID-19 shielding advice and vaccination priorities. We aimed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2021-10, Vol.10 (21), p.5125
Hauptverfasser: Emes, David, Hüls, Anke, Baumer, Nicole, Dierssen, Mara, Puri, Shiela, Russell, Lauren, Sherman, Stephanie L, Strydom, Andre, Bargagna, Stefania, Brandão, Ana Cláudia, Costa, Alberto C S, Feany, Patrick T, Chicoine, Brian Allen, Ghosh, Sujay, Rebillat, Anne-Sophie, Sgandurra, Giuseppina, Valentini, Diletta, Rohrer, Tilman R, Levin, Johannes, Lakhanpaul, Monica, On Behalf Of The Trisomy Research Society Covid-Initiative Study Group
Format: Artikel
Sprache:eng
Schlagworte:
Age
Clinical medicine
Coronaviruses
COVID-19
Down syndrome
Gender
Hospitalization
Mortality
Obesity
Pandemics
Pediatrics
Population
Respiratory diseases
Respiratory distress syndrome
Risk factors
Severe acute respiratory syndrome coronavirus 2
Surveillance
Ventilators
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Adults with Down Syndrome (DS) are at higher risk for severe outcomes of coronavirus disease 2019 (COVID-19) than the general population, but evidence is required to understand the risks for children with DS, which is necessary to inform COVID-19 shielding advice and vaccination priorities. We aimed to determine the epidemiological and clinical characteristics of COVID-19 in children with DS. Using data from an international survey obtained from a range of countries and control data from the United States, we compared the prevalence of symptoms and medical complications and risk factors for severe outcomes between DS and non-DS paediatric populations with COVID-19. Hospitalised COVID-19 patients
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm10215125